| 摘要 |
The present invention relates to the use of at least one protease for the manufacture of a medicament for the treatment and/or prevention of ocular d iseases related to neoangiogenesis selected from the group consisting of age related macular degeneration (AMD), choroidal neovascularisation, Hippel-Li ndau Disease, iris neovascularisation, ischemic proliferative retinopathy, n eovascularisation of the Cornea, and proliferative sickle cell retinopathy, wherein the at least one protease is selected from the group consisting of p lant, non-mammalian animal and microbial proteases.
|
